Robert Alan Nagourney

An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/ <i>wingless</i> signaling pathway

Foster C. Gonsalves, Keren Klein, Brittany B. Carson et al. · Proceedings of the National Academy of Sciences · 2011 · 333 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Gemcitabine Plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Breast Cancer Patients

Robert Alan Nagourney, John S. Link, Jonathan B. Blitzer et al. · Journal of Clinical Oncology · 2000 · 105 citations

Medicine, Oncology, Pharmacology +15

Phase II Trial of Gemcitabine plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Ovarian Cancer Patients

Robert Alan Nagourney, Cheryl A. Brewer, Stephen E. Radecki et al. · Gynecologic Oncology · 2002 · 94 citations

Medicine, Gynecology, Oncology +17

A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.

Lawrence Panasci, Dianna Green, Robert Alan Nagourney et al. · PubMed · 1977 · 69 citations

Medicine, Pharmacology, Drug Metabolism +7

Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: A Phase II Study of the Gynecologic Oncology Group

Cheryl A. Brewer, John A. Blessing, Robert Alan Nagourney et al. · Gynecologic Oncology · 2006 · 58 citations

Medicine, Gynecology, Oncology +15